Odevixibat

odevixibat · Albireo Pharma, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Odevixibat, covering 2023-11-02 to 2026-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) [Phase 3]

See pricing